GENT, Belgium, April 05, 2022 (GLOBE NEWSWIRE) -- eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with a full platform of integrated capabilities ...

etherna immunotherapies NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a strategic collaboration with Dropshot Therapeutics ...

NIEL, Belgium and BOSTON, Jan. 9, 2025 /CNW/ -- etherna immunotherapies NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...

NIEL, Belgium, July 27, 2021 /PRNewswire/ -- eTheRNA immunotherapies NV ('eTheRNA' or the 'Company'), a clinical-stage company developing mRNA-bas... Menu icon A vertical stack of three evenly ...

- The objective is to make RNA therapeutics accessible to global patient populations - Makes large scale decentralized RNA production economically viable NEIL, Belgium and BRUSSELS, June 29, 2021 ...

Then there’s Etherna, a Belgium- and Boston-based biotech formed in 2013 that touts both mRNA and LNP technologies. In 2022, the company raised a 39 million euro series B2 round that included ...

Dr. Florence Lambolez, director Pharmacology at eTheRNA, stated, "In our newly developed LNPs,the mRNAs encoding therapeutic proteins are protected against degradation during their intratumoral ...

Almirall has partnered with etherna for the development of mRNA-based therapies for the treatment of severe skin diseases, including nonmelanoma skin cancer, the companies announced in a press ...

eTheRNA immunotherapies has secured EUR 24 million in a Series A investment round with venture capital enabling the company to continue the development of its proprietary TriMix mRNA-based ...

TriMix-MEL (ECI-003), a rationally designed mRNA immunotherapy based on the unique TriMix platform, starts Phase Ib trial in adjuvant melanoma patients eTheRNA immunotherapies, a clinical-stage ...

The positions in the table below reflect the eTheRNA immunotherapies NV's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...